289 related articles for article (PubMed ID: 26565550)
1. Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease.
Cairns EA; Toguri JT; Porter RF; Szczesniak AM; Kelly ME
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):253-65. PubMed ID: 26565550
[TBL] [Abstract][Full Text] [Related]
2. Endocannabinoid System and Ocular Vascularization.
Iancu R; Coman IC; Barac C; Hammoud MA; Cherecheanu AP
Nepal J Ophthalmol; 2018 Jul; 10(20):168-175. PubMed ID: 31056561
[TBL] [Abstract][Full Text] [Related]
3. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA
Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127
[TBL] [Abstract][Full Text] [Related]
4. The Endocannabinoid System as a Therapeutic Target in Glaucoma.
Cairns EA; Baldridge WH; Kelly ME
Neural Plast; 2016; 2016():9364091. PubMed ID: 26881140
[TBL] [Abstract][Full Text] [Related]
5. Targeting the endocannabinoid system: future therapeutic strategies.
Aizpurua-Olaizola O; Elezgarai I; Rico-Barrio I; Zarandona I; Etxebarria N; Usobiaga A
Drug Discov Today; 2017 Jan; 22(1):105-110. PubMed ID: 27554802
[TBL] [Abstract][Full Text] [Related]
6. Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease.
Kokona D; Georgiou PC; Kounenidakis M; Kiagiadaki F; Thermos K
Neural Plast; 2016; 2016():8373020. PubMed ID: 26881135
[TBL] [Abstract][Full Text] [Related]
7. [The role of endocannabinoid system in physiological and pathological processes in the eye].
Nadolska K; Goś R
Klin Oczna; 2008; 110(10-12):392-6. PubMed ID: 19195174
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications.
Onaivi ES
Int Rev Neurobiol; 2009; 88():335-69. PubMed ID: 19897083
[TBL] [Abstract][Full Text] [Related]
9. Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review.
Patil AS; Mahajan UB; Agrawal YO; Patil KR; Patil CR; Ojha S; Sharma C; Goyal SN
Biomed Pharmacother; 2020 Dec; 132():110889. PubMed ID: 33113429
[TBL] [Abstract][Full Text] [Related]
10. Focus on cannabinoids and synthetic cannabinoids.
Le Boisselier R; Alexandre J; Lelong-Boulouard V; Debruyne D
Clin Pharmacol Ther; 2017 Feb; 101(2):220-229. PubMed ID: 27861784
[TBL] [Abstract][Full Text] [Related]
11. Toward a translational approach to targeting the endocannabinoid system in posttraumatic stress disorder: a critical review of preclinical research.
Papini S; Sullivan GM; Hien DA; Shvil E; Neria Y
Biol Psychol; 2015 Jan; 104():8-18. PubMed ID: 25448242
[TBL] [Abstract][Full Text] [Related]
12. The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases.
Lowe H; Toyang N; Steele B; Bryant J; Ngwa W
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502379
[TBL] [Abstract][Full Text] [Related]
13. The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
Río CD; Millán E; García V; Appendino G; DeMesa J; Muñoz E
Biochem Pharmacol; 2018 Nov; 157():122-133. PubMed ID: 30138623
[TBL] [Abstract][Full Text] [Related]
14. The Endocannabinoid System: A Target for Cancer Treatment.
Laezza C; Pagano C; Navarra G; Pastorino O; Proto MC; Fiore D; Piscopo C; Gazzerro P; Bifulco M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979368
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Use of Synthetic Cannabinoids: Still an OpenIssue?
De Luca MA; Fattore L
Clin Ther; 2018 Sep; 40(9):1457-1466. PubMed ID: 30180974
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids and Cancer.
Velasco G; Sánchez C; Guzmán M
Handb Exp Pharmacol; 2015; 231():449-72. PubMed ID: 26408171
[TBL] [Abstract][Full Text] [Related]
18. Role of lipids and lipid signaling in the development of cannabinoid tolerance.
Martin BR
Life Sci; 2005 Aug; 77(14):1543-58. PubMed ID: 15949820
[TBL] [Abstract][Full Text] [Related]
19. Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic Disease.
Gotfried J; Naftali T; Schey R
Gastroenterology; 2020 Jul; 159(1):62-80. PubMed ID: 32333910
[TBL] [Abstract][Full Text] [Related]
20. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
O'Brien M; McDougall JJ
Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
